Chronic myelogenous leukemia in T cell lymphoid blastic phase achieving durable complete cytogenetic and molecular remission with imatinib mesylate (STI571; Gleevec) therapy
Open Access
- 23 May 2002
- Vol. 94 (11) , 2996-2999
- https://doi.org/10.1002/cncr.10576
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeNew England Journal of Medicine, 2001
- T-lymphoid blast crisis in chronic myeloid leukemiaAmerican Journal of Hematology, 1991
- Phenotypic and genotypic analysis of chronic myelogenous leukaemia with T lymphoblastic and megakaryoblastic mixed crisisBritish Journal of Haematology, 1987
- Persistence of chronic myelocytic leukemia despite deletion of rearranged bcr/c-abl sequences in blast crisis.The Journal of Experimental Medicine, 1986
- T-CELL RECEPTOR β-CHAIN GENE REARRANGEMENT IN A CASE OF Ph1-POSITIVE CHRONIC MYELOID LEUKAEMIA BLAST CRISISBritish Journal of Haematology, 1986
- Lymphoid crisis with T-cell phenotypes in a patient with Philadelphia chromosome negative chronic myeloid leukaemiaBritish Journal of Haematology, 1985
- Characterization of extramedullary tumors in a case of Ph-positive chronic myelogenous leukemia: Possible involvement of immature T lymphocytesCancer Genetics and Cytogenetics, 1985
- Ph1-positive T lymphoblastic transformationLeukemia Research, 1984
- Ph1-POSITIVE T LYMPHOBLASTIC TRANSFORMATION OF CHRONIC GRANULOCYTIC LEUKAEMIA IN A LYMPH NODEThe Lancet, 1982
- CHRONIC MYELOID LEUKAEMIA BLAST CRISIS WITH T-CELL FEATURESBritish Journal of Haematology, 1982